UCB SA UCBJY
154.96 USD -1.03 (-0.66%)
As ofNov 19, 2026, 3:59 PM EST
154.80 Day range 155.93
110.55 52-week range 168.76
- YTD
- +10.88%
- 1 year
- +17.00%
News
benzinga.com What's Going On with MoonLake Immunotherapeutics Stock on Thursday? MoonLake stock rallies after AbbVie HS data misses competitor benchmarks, reinforcing sonelokimab's competitive positioning ahead of 2027 launch plans.
seekingalpha.com UCB SA (UCBJY) Discusses EADV Data Highlights and Long-Term Impact of BIMZELX in Dermatology Transcript UCB SA (UCBJY) Discusses EADV Data Highlights and Long-Term Impact of BIMZELX in Dermatology Transcript
defenseworld.net UCB (OTCMKTS:UCBJY) Reaches New 1-Year Low – Should You Sell? UCB SA (OTCMKTS:UCBJY - Get Free Report)'s stock price reached a new 52-week low during trading on Wednesday. The company traded as low as $116.29 and last traded at $116.38, with a volume of 6770…
seekingalpha.com UCB SA (UCBJY) Presents at J.P. Morgan CEO Call Series Transcript UCB SA (UCBJY) Presents at J.P. Morgan CEO Call Series Transcript
seekingalpha.com UCB SA (UCBJY) Presents at Bank of America Global Healthcare Conference 2026 Transcript UCB SA (UCBJY) Presents at Bank of America Global Healthcare Conference 2026 Transcript
zacks.com UCB (UCBJY) Upgraded to Buy: Here's Why UCB (UCBJY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
zacks.com Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers Trump's MFN push expands to nine mid-sized drugmakers, bringing 26 companies under agreements covering 89% of the branded drug market.
defenseworld.net UCB (OTCMKTS:UCBJY) Stock Crosses Below Two Hundred Day Moving Average – Should You Sell? Shares of UCB SA (OTCMKTS:UCBJY - Get Free Report) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $145.86 and traded as low as $122.54.…
seekingalpha.com UCB SA (UCBJY) Q2 2026 Earnings Call Transcript UCB SA (UCBJY) Q2 2026 Earnings Call Transcript
defenseworld.net UCB SA (OTCMKTS:UCBJY) Short Interest Down 60.4% in July UCB SA (OTCMKTS:UCBJY - Get Free Report) was the target of a significant drop in short interest in the month of July. As of July 15th, there was short interest totaling 2,283 shares, a drop of 60.4%…
seekingalpha.com UCB SA (UCBJY) Analyst/Investor Day Transcript UCB SA (UCBJY) Analyst/Investor Day Transcript
zacks.com UCB (UCBJY) Upgraded to Strong Buy: Here's What You Should Know UCB (UCBJY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
reuters.com Belgium's UCB in autoimmune drug deal with Antengene Belgian drugmaker UCB has entered into an agreement to licence Antengene's experimental autoimmune disease therapy ATG-201 and associated technology, paying $60 million up front and over $1.1…
seekingalpha.com UCB SA (UCBJY) Q4 2025 Earnings Call Transcript UCB SA (UCBJY) Q4 2025 Earnings Call Transcript
seekingalpha.com UCB SA (UCBJY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript UCB SA (UCBJY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
defenseworld.net Minerva Neurosciences (NASDAQ:NERV) & UCB (OTCMKTS:UCBJY) Head to Head Analysis UCB (OTCMKTS:UCBJY - Get Free Report) and Minerva Neurosciences (NASDAQ: NERV - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses…
defenseworld.net UCB (OTCMKTS:UCBJY) Share Price Crosses Above 50 Day Moving Average – What’s Next? UCB SA (OTCMKTS:UCBJY - Get Free Report)'s stock price crossed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $137.71 and traded as high as…
zacks.com Recent Price Trend in UCB (UCBJY) is Your Friend, Here's Why If you are looking for stocks that are well positioned to maintain their recent uptrend, UCB (UCBJY) could be a great choice. It is one of the several stocks that passed through our "Recent Price…
zacks.com UCB (UCBJY) Is a Great Choice for 'Trend' Investors, Here's Why If you are looking for stocks that are well positioned to maintain their recent uptrend, UCB (UCBJY) could be a great choice. It is one of the several stocks that passed through our "Recent Price…
zacks.com All You Need to Know About UCB (UCBJY) Rating Upgrade to Strong Buy UCB (UCBJY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
